You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Figure INF-7:  HCV prevalence among injecting drug users under age 25 – studies with national and subnational coverage, 2002 to 2003

Figure INF-07

Notes:

Black square = samples with national coverage; blue triangle = samples with subnational (including local or regional) coverage,

Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Data for Slovenia are limited to prevalence among IDUs in treatment and may not be representative of prevalence among IDUs who are not in treatment.

Sources:

Reitox national focal points. For primary sources, study details and data before 2002, see [Table INF-12] in the 2005 statistical bulletin.